# An Observational Study of Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip Involvement

> **NCT02293681** · — · TERMINATED · sponsor: **Janssen Research & Development, LLC** · enrollment: 76 (actual)

## Conditions studied

- Spondylitis, Ankylosing

## Interventions

- **DRUG:** Infliximab
- **DRUG:** NSAIDs
- **DRUG:** DMARDs

## Key facts

- **NCT ID:** NCT02293681
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2015-04-10
- **Primary completion:** 2017-05-31
- **Final completion:** 2017-05-31
- **Target enrollment:** 76 (ACTUAL)
- **Why stopped:** The project was stopped by 31-May-2017 because of internal owner decision from out of balance enrollment from two groups.
- **Last updated:** 2017-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02293681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02293681, "An Observational Study of Infliximab in Participants Suffering From Ankylosing Spondylitis With Hip Involvement". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02293681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*